Shire Fights Latest Class Rep In ADHD Drug Antitrust Suit
Shire has urged a Massachusetts federal court to reject a third potential representative for a class of direct purchasers suing over the alleged delay of a generic version of the ADHD...To view the full article, register now.
Already a subscriber? Click here to view full article